Dyne Therapeutics, Inc. (DYN)

Last Year

03-May-23 -- 02-May-24

Time Period:
($504.62K) Net Amount
Buy:0--
Sell:($504.62K)$9.41 - $10.72

Company Sentiment

Other

Other

Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Sentiment Breakdown by Insider
0
(3)
0
(2)
1
(1)
14
0
8
+1
0
+2
0
+3

Two Year Chart

03-May-22 -- 02-May-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Last TransactionLast Three Months
SEC FilingTransactionInsiderSentimentCompanyHoldings ChangeBuy AmountSell AmountBuy Price RangeSell Price Range
28-Feb-24 7:13 PM
View: 		28-Feb-24
Sale (Planned)
($900.23K)
Atlas Venture Fund Xi, L.P.
10% Owner
Insider Trading Sentiment for Atlas Venture Fund Xi, L.P. at Dyne Therapeutics, Inc. (DYN):Dyne Therapeutics, Inc. - DYN10%
7.33M to 8.05M		0
0
---- Show TxnsShow Insider Trades
11-Jan-24 4:31 PM
View: 		09-Jan-24
Purchase
$30.00M
Kersten Dirk
Director
10% Owner
Insider Trading Sentiment for Kersten Dirk at Dyne Therapeutics, Inc. (DYN):Dyne Therapeutics, Inc. - DYN28%
6.13M to 7.85M		0
0
---- Show TxnsShow Insider Trades
13-Mar-24 6:04 AM
View: 		11-Mar-24
Sale (Planned)
($58.90K)
High Susanna Gatti
Chief Operating Officer
Insider Trading Sentiment for High Susanna Gatti at Dyne Therapeutics, Inc. (DYN):Dyne Therapeutics, Inc. - DYN42%
110.48K to 156.8K		0
($59.49K)
(5%)		--$9.41 - $10.72 Show TxnsShow Insider Trades
05-Mar-24 5:08 PM
View: 		01-Mar-24
Private Sale (Planned)
($1.40M)
Rhodes Jason P
Director
Insider Trading Sentiment for Rhodes Jason P at Dyne Therapeutics, Inc. (DYN):Dyne Therapeutics, Inc. - DYN(19%)
9.87M to 8.0M		0
0
---- Show TxnsShow Insider Trades
12-Mar-24 9:58 PM
View: 		12-Mar-24
Sale (Planned)
($26.35K)
Farwell Wildon
Chief Medical Officer
Insider Trading Sentiment for Farwell Wildon at Dyne Therapeutics, Inc. (DYN):Dyne Therapeutics, Inc. - DYN62%
92.66K to 150.56K		0
($46.18K)
(5%)		--$10.41 - $10.72 Show TxnsShow Insider Trades
12-Mar-24 9:42 PM
View: 		11-Mar-24
Private Sale (Planned)
($53.48K)
Beskrovnaya Oxana
Chief Scientific Officer
Insider Trading Sentiment for Beskrovnaya Oxana at Dyne Therapeutics, Inc. (DYN):Dyne Therapeutics, Inc. - DYN72%
88.73K to 152.35K		0
($44.69K)
(5%)		--$9.41 - $10.72 Show TxnsShow Insider Trades
13-Mar-24 6:04 AM
View: 		11-Mar-24
Sale (Planned)
($45.66K)
McNeill Jonathan
Chief Business Officer
Insider Trading Sentiment for McNeill Jonathan at Dyne Therapeutics, Inc. (DYN):Dyne Therapeutics, Inc. - DYN113%
65.39K to 139.41K		0
($38.39K)
(6%)		--$9.41 - $10.72 Show TxnsShow Insider Trades
12-Mar-24 9:57 PM
View: 		11-Mar-24
Sale (Planned)
($67.54K)
Scalzo Richard William
SVP, Head of Finance & Admin.
Insider Trading Sentiment for Scalzo Richard William at Dyne Therapeutics, Inc. (DYN):Dyne Therapeutics, Inc. - DYN117%
54.87K to 119.28K		0
($41.48K)
(7%)		--$9.41 - $10.72 Show TxnsShow Insider Trades
12-Mar-24 9:56 PM
View: 		11-Mar-24
Sale (Planned)
($202.93K)
Brumm Joshua T
CEO & President
Director
Insider Trading Sentiment for Brumm Joshua T at Dyne Therapeutics, Inc. (DYN):Dyne Therapeutics, Inc. - DYN67%
322.48K to 538.0K		0
($274.40K)
(8%)		--$9.41 - $10.72 Show TxnsShow Insider Trades
05-Mar-24 5:07 PM
View: 		01-Mar-24
Sale (Planned)
($513.82K)
Atlas Venture Opportunity F...
10% Owner
Insider Trading Sentiment for Atlas Venture Opportunity Fund I, L.P. at Dyne Therapeutics, Inc. (DYN):Dyne Therapeutics, Inc. - DYN(2%)
2.35M to 2.31M		0
0
---- Show TxnsShow Insider Trades